Literature DB >> 7576305

Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy.

M H Tuszynski1, F H Gage.   

Abstract

Multiple genetic and epigenetic events determine neuronal phenotype during nervous system development. After the mature mammalian neuronal phenotype has been determined it is usually static for the remainder of life, unless an injury or degenerative event occurs. Injured neurons may suffer one of three potential fates: death, persistent atrophy, or recovery. The ability of an injured adult neuron to recover from injury in adulthood may be determined by events that also influence neuronal phenotype during development, including expression of growth-related genes and responsiveness to survival and growth signals in the environment. The latter signals include neurotrophic factors and substrate molecules that promote neurite growth. Several adult CNS regions exhibit neurotrophic-factor responsiveness, including the basal forebrain, entorhinal cortex, hippocampus, thalamus, brainstem, and spinal cord. The specificity of neurotrophic-factor responsiveness in these regions parallels patterns observed during development. In addition, neurons of several CNS regions extend neurites after injury when presented with growth-promoting substrates. When both neurotrophic factors and growth-promoting substrates are provided to adult rats that have undergone bilateral fimbria-fornix lesions, then partial morphological and behavioral recovery can be induced. Gene therapy is one useful tool for providing these substances. Thus, the mature CNS remains robustly responsive to signals that shape nervous system development, and is highly plastic when stimulated by appropriate cues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576305     DOI: 10.1007/BF02740673

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  94 in total

1.  Myelin-associated inhibitors of neurite growth and regeneration in the CNS.

Authors:  M E Schwab
Journal:  Trends Neurosci       Date:  1990-11       Impact factor: 13.837

2.  Basal forebrain cell loss following fimbria/fornix transection.

Authors:  M H Tuszynski; D M Armstrong; F H Gage
Journal:  Brain Res       Date:  1990-02-05       Impact factor: 3.252

Review 3.  Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth.

Authors:  D Monard
Journal:  Trends Neurosci       Date:  1988-12       Impact factor: 13.837

4.  Axons from CNS neurons regenerate into PNS grafts.

Authors:  P M Richardson; U M McGuinness; A J Aguayo
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

5.  Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain.

Authors:  C R Buck; H J Martinez; I B Black; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development.

Authors:  K R Thomas; M R Capecchi
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

7.  Individual differences in aging: behavioral and neurobiological correlates.

Authors:  A L Markowska; W S Stone; D K Ingram; J Reynolds; P E Gold; L H Conti; M J Pontecorvo; G L Wenk; D S Olton
Journal:  Neurobiol Aging       Date:  1989 Jan-Feb       Impact factor: 4.673

8.  Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery.

Authors:  M H Tuszynski; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Behavioural Effect of Engineered Cells that Synthesize l-dopa or Dopamine after Grafting into the Rat Neostriatum.

Authors:  Philippe Horellou; Lionel Marlier; Alain Privat; Jacques Mallet
Journal:  Eur J Neurosci       Date:  1990-01       Impact factor: 3.386

10.  Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression.

Authors:  M B Rosenberg; T Friedmann; R C Robertson; M Tuszynski; J A Wolff; X O Breakefield; F H Gage
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  9 in total

Review 1.  The potential application of gene therapy in the treatment of traumatic brain injury.

Authors:  Fang Shen; Liang Wen; Xiaofeng Yang; Weiguo Liu
Journal:  Neurosurg Rev       Date:  2007-08-09       Impact factor: 3.042

Review 2.  Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support.

Authors:  Samuel E Marsh; Mathew Blurton-Jones
Journal:  Neurochem Int       Date:  2017-02-20       Impact factor: 3.921

3.  Spinal electro-magnetic stimulation combined with transgene delivery of neurotrophin NT-3 and exercise: novel combination therapy for spinal contusion injury.

Authors:  Hayk A Petrosyan; Valentina Alessi; Arsen S Hunanyan; Sue A Sisto; Victor L Arvanian
Journal:  J Neurophysiol       Date:  2015-09-30       Impact factor: 2.714

4.  Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord.

Authors:  Gábor Márton; Dóra Tombácz; Judit S Tóth; András Szabó; Zsolt Boldogköi; Adám Dénes; Akos Hornyák; Antal Nógrádi
Journal:  BMC Neurosci       Date:  2010-05-29       Impact factor: 3.288

5.  Neural stem cells improve memory in an inducible mouse model of neuronal loss.

Authors:  Tritia R Yamasaki; Mathew Blurton-Jones; Debbi A Morrissette; Masashi Kitazawa; Salvatore Oddo; Frank M LaFerla
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

6.  Preparation of brain-derived neurotrophic factor- and neurotrophin-3-secreting Schwann cells by infection with a retroviral vector.

Authors:  S T Sayers; N Khan; Y Ahmed; R Shahid; T Khan
Journal:  J Mol Neurosci       Date:  1998-04       Impact factor: 3.444

7.  Inhibition of retinal ganglion cell axonal outgrowth through the Amino-Nogo-A signaling pathway.

Authors:  Yan Huo; Xiao-Lei Yin; Shu-Xing Ji; Huan Zou; Min Lang; Zheng Zheng; Xiao-Feng Cai; Wei Liu; Chun-Lin Chen; Yuan-Guo Zhou; Rong-Di Yuan; Jian Ye
Journal:  Neurochem Res       Date:  2013-04-12       Impact factor: 3.996

8.  Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord.

Authors:  Lisa Schnell; Arsen S Hunanyan; William J Bowers; Philip J Horner; Howard J Federoff; Miriam Gullo; Martin E Schwab; Lorne M Mendell; Victor L Arvanian
Journal:  Eur J Neurosci       Date:  2011-10-13       Impact factor: 3.386

9.  Nerve Growth Factor Is Responsible for Exercise-Induced Recovery of Septohippocampal Cholinergic Structure and Function.

Authors:  Joseph M Hall; Fernando Gomez-Pinilla; Lisa M Savage
Journal:  Front Neurosci       Date:  2018-11-01       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.